These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22988030)

  • 1. Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophages.
    Bruns H; Stegelmann F; Fabri M; Döhner K; van Zandbergen G; Wagner M; Skinner M; Modlin RL; Stenger S
    J Immunol; 2012 Oct; 189(8):4069-78. PubMed ID: 22988030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of phagosomal functionality for growth restriction of Mycobacterium tuberculosis in primary human macrophages.
    Welin A; Raffetseder J; Eklund D; Stendahl O; Lerm M
    J Innate Immun; 2011; 3(5):508-18. PubMed ID: 21576918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
    Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
    PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib Triggers Phagolysosome Acidification and Antimicrobial Activity against Mycobacterium bovis Bacille Calmette-Guérin in Glucocorticoid-Treated Human Macrophages.
    Steiger J; Stephan A; Inkeles MS; Realegeno S; Bruns H; Kröll P; de Castro Kroner J; Sommer A; Batinica M; Pitzler L; Kalscheuer R; Hartmann P; Plum G; Stenger S; Pellegrini M; Brachvogel B; Modlin RL; Fabri M
    J Immunol; 2016 Jul; 197(1):222-32. PubMed ID: 27233968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib-sensitive tyrosine kinases regulate mycobacterial pathogenesis and represent therapeutic targets against tuberculosis.
    Napier RJ; Rafi W; Cheruvu M; Powell KR; Zaunbrecher MA; Bornmann W; Salgame P; Shinnick TM; Kalman D
    Cell Host Microbe; 2011 Nov; 10(5):475-85. PubMed ID: 22100163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein.
    Elzinga BM; Nyhan MJ; Crowley LC; O'Donovan TR; Cahill MR; McKenna SL
    Am J Hematol; 2013 Jun; 88(6):455-62. PubMed ID: 23440701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML.
    O'Hare T; Pollock R; Stoffregen EP; Keats JA; Abdullah OM; Moseson EM; Rivera VM; Tang H; Metcalf CA; Bohacek RS; Wang Y; Sundaramoorthi R; Shakespeare WC; Dalgarno D; Clackson T; Sawyer TK; Deininger MW; Druker BJ
    Blood; 2004 Oct; 104(8):2532-9. PubMed ID: 15256422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome.
    Van Zandt KE; Sow FB; Florence WC; Zwilling BS; Satoskar AR; Schlesinger LS; Lafuse WP
    J Leukoc Biol; 2008 Sep; 84(3):689-700. PubMed ID: 18586980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mycobacterium tuberculosis SecA2 system subverts phagosome maturation to promote growth in macrophages.
    Sullivan JT; Young EF; McCann JR; Braunstein M
    Infect Immun; 2012 Mar; 80(3):996-1006. PubMed ID: 22215736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages.
    Malik ZA; Iyer SS; Kusner DJ
    J Immunol; 2001 Mar; 166(5):3392-401. PubMed ID: 11207296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro sensitivity to imatinib-induced inhibition of ABL kinase activity is predictive of molecular response in patients with de novo CML.
    White D; Saunders V; Lyons AB; Branford S; Grigg A; To LB; Hughes T
    Blood; 2005 Oct; 106(7):2520-6. PubMed ID: 15956284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib.
    Dewar AL; Cambareri AC; Zannettino AC; Miller BL; Doherty KV; Hughes TP; Lyons AB
    Blood; 2005 Apr; 105(8):3127-32. PubMed ID: 15637141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner.
    Seggewiss R; Loré K; Greiner E; Magnusson MK; Price DA; Douek DC; Dunbar CE; Wiestner A
    Blood; 2005 Mar; 105(6):2473-9. PubMed ID: 15572591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib mesylate causes genome-wide transcriptional changes in systemic sclerosis fibroblasts in vitro.
    Hinchcliff M; Huang CC; Ishida W; Fang F; Lee J; Jafari N; Wilkes M; Bhattacharyya S; Leof E; Varga J
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S86-96. PubMed ID: 22691216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosolic access of Mycobacterium tuberculosis: critical impact of phagosomal acidification control and demonstration of occurrence in vivo.
    Simeone R; Sayes F; Song O; Gröschel MI; Brodin P; Brosch R; Majlessi L
    PLoS Pathog; 2015 Feb; 11(2):e1004650. PubMed ID: 25658322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
    Croom KF; Perry CM
    Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tyrosine kinase inhibitor dasatinib reduces the growth of intracellular Mycobacterium tuberculosis despite impairing T-cell function.
    Wehrstedt S; Kubis J; Zimmermann A; Bruns H; Mayer D; Grieshober M; Stenger S
    Eur J Immunol; 2018 Nov; 48(11):1892-1903. PubMed ID: 30242834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells.
    Wu J; Meng F; Lu H; Kong L; Bornmann W; Peng Z; Talpaz M; Donato NJ
    Blood; 2008 Apr; 111(7):3821-9. PubMed ID: 18235045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLK1 inhibitors synergistically potentiate HDAC inhibitor lethality in imatinib mesylate-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivo.
    Dasmahapatra G; Patel H; Nguyen T; Attkisson E; Grant S
    Clin Cancer Res; 2013 Jan; 19(2):404-14. PubMed ID: 23204129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide identification of genes required for yeast growth under imatinib stress: vacuolar H+-ATPase function is an important target of this anticancer drug.
    dos Santos SC; Sá-Correia I
    OMICS; 2009 Jun; 13(3):185-98. PubMed ID: 19260806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.